最新更新 :
16/01/2021
Infostab
药品清单
简要表
不兼容性所搜
不兼容性表
引用文献
研究小組
海报
鏈接
作者
使用指南
时讯
引用文献 4433
种类 :
文献
网络联接 :
https://doi.org/10.1016/j.clinthera.2020.01.017
研究小組 :
Philadelphie - Philadelphia College of Pharmacy and Science
作者 :
Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.
标题 :
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
引用文献 :
Clin Ther ; 42, 3: 475-485. 2020
可信 :
物理稳定性 :
化学稳定性 :
其它方法 :
评论 :
药品清单
Dexamethasone sodium phosphate
1 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Furosemide
10 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Haloperidol
5 mg
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Hydrocortisone sodium succinate
1 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Dexamethasone sodium phosphate
1 mg/ml
+
5 mg/ml
+
Furosemide
10 mg/ml
+
5 mg/ml
+
Haloperidol
5 mg
+
5 mg/ml
+
Hydrocortisone sodium succinate
1 mg/ml
+
5 mg/ml
+
Insulin glulisine
1 U/ml
+
5 mg/ml
+
Labetalol hydrochloride
2 mg/ml
+
5 mg/ml
+
Phenytoin sodium
5 mg/ml
+
Insulin glulisine
1 U/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Labetalol hydrochloride
2 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Phenytoin sodium
5 mg/ml
+
Imipenem-Cilastatin / Relebactam
5 mg/ml
+
Mentions Légales